- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
Results
9
Companies which are potentially undervalued and in an acceptable financial position.
9 companies
Dong-A Socio Holdings
Market Cap: ₩538.3b
Engages in the pharmaceutical business in South Korea.
A000640
₩81,200.00
7D
-5.1%
1Y
-30.5%
Hugel
Market Cap: ₩2.5t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩227,000.00
7D
-8.5%
1Y
-36.5%
Dong-A ST
Market Cap: ₩334.9b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩34,750.00
7D
-3.2%
1Y
-27.2%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩122,500.00
7D
-8.9%
1Y
-25.5%
PharmaResearch
Market Cap: ₩3.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩318,500.00
7D
-6.5%
1Y
-46.2%
Medy-Tox
Market Cap: ₩456.2b
Operates as a biopharmaceutical company in South Korea.
A086900
₩70,000.00
7D
-6.3%
1Y
-56.6%
Hanmi Pharm
Market Cap: ₩4.5t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩356,500.00
7D
-17.1%
1Y
23.4%
SK Biopharmaceuticals
Market Cap: ₩5.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩74,600.00
7D
-12.1%
1Y
-24.6%
ST PharmLtd
Market Cap: ₩2.7t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩128,100.00
7D
-0.5%
1Y
49.1%